Possible associations between antioxidant enzyme polymorphisms and metabolic abnormalities in patients with schizophrenia

This study investigated the possible association between common and potentially functional polymorphisms of antioxidant enzymes and metabolic abnormalities in patients with schizophrenia. The possible associations of the glutathione S-transferase (GST) M1 null and GSTT1 null genotypes, and the super...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuropsychiatric disease and treatment 2013-01, Vol.9 (default), p.1683-1698
Hauptverfasser: Saruwatari, Junji, Yasui-Furukori, Norio, Kamihashi, Ryoko, Yoshimori, Yuki, Oniki, Kentaro, Tsuchimine, Shoko, Noai, Madoka, Sato, Yasushi, Nakagami, Taku, Sugawara, Norio, Saito, Manabu, Fujii, Akira, Kajiwara, Ayami, Mihara, Shuichi, Ogata, Yasuhiro, Kaneko, Sunao, Nakagawa, Kazuko
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This study investigated the possible association between common and potentially functional polymorphisms of antioxidant enzymes and metabolic abnormalities in patients with schizophrenia. The possible associations of the glutathione S-transferase (GST) M1 null and GSTT1 null genotypes, and the superoxide dismutase 2 (SOD2) Val16Ala polymorphism with the risks of being overweight and having metabolic syndrome were examined using a logistic regression analysis in 154 schizophrenic Japanese patients and 203 controls. Among smokers with schizophrenia, the risks of being overweight and having decreased high-density lipoprotein cholesterol were significantly higher in those with the GSTM1 null genotype than in those with the present genotype (odds ratio 3.20 and 3.15, P=0.03 and P=0.04, respectively), while among nonsmokers with schizophrenia, the risk of an abnormal waist circumference was lower in those with the GSTM1 null genotype (odds ratio 0.34, P=0.04). The risk of a decreased high-density lipoprotein cholesterol level was significantly higher in patients with the combined GSTM1 null and GSTT1 present genotypes than in those with the present genotypes of both genes (odds ratio 3.60, P
ISSN:1176-6328
1176-6328
1178-2021
DOI:10.2147/NDT.S52585